# US 2026/0085358 A1 · Relative and absolute cell-free dna concentrations for clinical utilities

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0085358 A1
- Document ID: US20260085358A1
- Status: Published application
- Kind: A1
- Application number: 19/264,406
- Filed: 2025-07-09
- Published: 2026-03-26
- Earliest claimed: 2024-07-09
- Assignees: Centre for Novostics
- Applicants: Centre for Novostics
- Inventors: Yuk-Ming Dennis Lo; Kwan Chee Chan; Peiyong Jiang; Wai Kei Lam; Yasine Malki; Guannan Kang
- Web page: https://patentgrep.com/patent/US20260085358A1

## CPC

- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- G16B 40/20: Supervised data analysis
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6881: for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
- C12Q 1/6883: for diseases caused by alterations of genetic material
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- C12Q 2600/166: Oligonucleotides used as internal standards, controls or normalisation probes
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

Some techniques of the present disclosure can use size and/or end motifs of cell-free DNA fragments to determine a concentration of cell-free DNA (all or clinically-relevant) in a biological sample of a subject, e.g., as a mass per volume. For example, a measured amount of cell-free DNA fragments at a particular size can be used with one or more calibration amounts determined from one or more calibration samples to determine a concentration of cell-free DNA. As another example, the measured amount can be of cell-free DNA fragments having a set of one or more sequence motifs corresponding to ending sequences of the plurality of cell-free DNA fragments. Certain sequence motif(s) can be selected.

## Claims

### Claim 1

A method measuring a first concentration of all cell-free DNA in a biological sample of a subject, the method comprising:
measuring a first amount of a plurality of cell-free DNA fragments having a first size in the biological sample, wherein (1) the first size has an upper bound less than 231 bp and a lower bound less than 161 bp or (2) the first size has a lower bound greater than 160 bp and an upper bound greater than 230 bp; and
determining the first concentration of all cell-free DNA in the biological sample using the first amount and one or more calibration amounts of cell-free DNA fragments having the first size determined from one or more calibration samples, each having a known concentration of cell-free DNA.

### Claim 2 (depends on 1)

The method of claim 1, further comprising:
measuring a second amount of the plurality of cell-free DNA fragments in the biological sample having a set of one or more sequence motifs corresponding to ending sequences of the plurality of cell-free DNA fragments, wherein determining the first concentration of all cell-free DNA in the biological sample further uses the second amount and one or more additional calibration amounts determined from one or more additional calibration samples, each having a known concentration of cell-free DNA.

### Claim 3 (depends on 1)

The method of claim 1, wherein the one or more calibration amounts are a plurality of calibration amounts and the one or more calibration samples are a plurality of calibration samples, the method further comprising:
measuring other amounts of cell-free DNA fragments having other sizes, wherein determining the first concentration of all cell-free DNA in the biological sample includes using a machine learning model that (a) operates on the first amount and the other amounts and (b) is trained using a training set that include the plurality of calibration amounts and known concentrations of the plurality of calibration samples.

### Claim 4 (depends on 3)

The method of claim 3, wherein the other sizes are in a range of 21 bp to 600 bp.

### Claim 5 (depends on 4)

The method of claim 4, wherein the first size and the other sizes include all sizes within a range of 21 bp to 600 bp.

### Claim 6 (depends on 4)

The method of claim 4, wherein the first size and the other sizes include all sizes within a range 21 bp to 160 bp and 231 bp to 600 bp.

### Claim 7 (depends on 3)

The method claim 3, wherein the first size and the other sizes include a plurality of size ranges, each of a specified width, and wherein the first amount and the other amounts are each determine for one of the plurality of size ranges.

### Claim 8 (depends on 1)

The method of claim 1, wherein the first size has the upper bound less than 231 bp and the lower bound less than 161 bp.

### Claim 9 (depends on 1)

The method of claim 1, wherein the first size has the lower bound greater than 160 bp and the upper bound greater than 230 bp.

### Claim 10 (depends on 1)

The method of claim 1, wherein the first size is a size range.

### Claim 11 (depends on 1)

The method of claim 1, wherein the first amount is normalized by a total number of the plurality of cell-free DNA fragments.

### Claim 12

A method measuring a first concentration of all cell-free DNA in a biological sample of a subject, the method comprising:
measuring a first amount of a plurality of cell-free DNA fragments in the biological sample having a set of one or more sequence motifs corresponding to ending sequences of the plurality of cell-free DNA fragments; and
determining the first concentration of all cell-free DNA in the biological sample using the first amount and one or more calibration amounts of cell-free DNA fragments having the set of one or more sequence motifs determined from one or more calibration samples, each having a known concentration of cell-free DNA.

### Claim 13 (depends on 12)

The method of claim 12, wherein the first amount is measured using a probe-based technique.

### Claim 14 (depends on 12)

The method of claim 12, further comprising:
measuring a second amount of the plurality of cell-free DNA fragments having a first size in the biological sample, wherein (1) the first size has an upper bound less than 231 bp and a lower bound less than 161 bp or (2) the first size has a lower bound greater than 160 bp and an upper bound greater than 230 bp, wherein determining the first concentration of all cell-free DNA in the biological sample further uses the second amount and one or more additional calibration amounts determined from one or more additional calibration samples, each having a known concentration of cell-free DNA.

### Claim 15 (depends on 2)

The method of claim 2, wherein the one or more calibration samples are the one or more additional calibration samples.

### Claim 16 (depends on 12)

The method of claim 12, wherein the set of one or more sequence motifs is a set of sequence motifs.

### Claim 17 (depends on 16)

The method of claim 16, further comprising:
storing a set of reference F-profiles, wherein each reference F-profile of the set of reference F-profiles:
identifies, for each sequence motif of the set of sequence motifs, a proportion of cell-free DNA fragments having the sequence motif, and
is associated with a type of fragmentation factors;
determining a sample end-motif profile by measuring other amounts of cell-free DNA fragments having other sequence motifs corresponding to ending sequences of the plurality of cell-free DNA fragments, the sample end-motif profile including the first amount and the other amounts; and
determining proportional contributions of the set of reference F-profiles whose proportional aggregation provide the sample end-motif profile, wherein the proportional contributions sum to one,
wherein determining the first concentration of all cell-free DNA in the biological sample uses a first proportional contribution of a first reference F-profile of the set of reference F-profiles and one or more reference contributions determined from the one or more calibration samples.

### Claim 18 (depends on 17)

The method of claim 17, wherein the plurality of cell-free DNA fragments has a first size with a lower bound greater than 160 bp and an upper bound greater than 230 bp.

### Claim 19 (depends on 17)

The method of claim 17, wherein determining the first concentration of all cell-free DNA in the biological sample comprises comparing the first proportional contribution to the one or more reference contributions.

### Claim 20 (depends on 19)

The method of claim 19, wherein the one or more reference contributions are a plurality of reference contributions, and wherein comparing the first proportional contribution to the one or more reference contributions uses a calibration function determined using the plurality of reference contributions and the known concentrations.

### Claim at position 21

-65. (canceled)
